INVO Fertility, Inc. (IVF)

Import this data to Google Sheets with:

=jivedata("IVF","financials")

Full statements spill as a table. For one cell: =jivedata("IVF","Revenue") or =jivedata("IVF","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

INVO Fertility, Inc.

IVF • CIK 0001417926

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-6,767.155	$-8,125.496	$-7,237.356	$-5,928.361
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-8,006.826	$-9,118.751	$-5,486.346	$-5,379.438
Income Tax Expense (Benefit)	$27.786	$-22.913	$-150.371	$-150.371
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	—	—	$-5,335.975	$-5,285.221
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax	—	—	$-1,534.517	$-1,534.517
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax	—	—	$-16,452.562	$-16,452.562
Net Income (Loss) Attributable to Parent	$-8,034.612	$-9,095.838	$-23,323.054	$-5,285.221
Preferred Stock Dividends and Other Adjustments	—	—	$1,807.17	$1,807.17
Net Income (Loss) Available to Common Stockholders, Basic	—	$-9,346.473	$-25,130.224	$-25,130.224
Revenues	—	$6,532	$6,841.25	$7,531.121
Cost of Goods and Services Sold	—	—	$30.571	$88.823
Selling, General and Administrative Expense	$7,486.454	$9,078.804	$7,691.151	$8,023.629
Research and Development Expense	$165.945	$489.66	$4.88	$265.663
Impairment of Intangible Assets (Excluding Goodwill)	—	—	$1,397.353	$1,397.353
Gain (Loss) on Disposition of Other Assets	—	—	$-511.663	$-511.663
Depreciation, Depletion and Amortization, Nonproduction	$200.894	$919.603	$677.364	$561.436
Costs and Expenses	—	—	$14,078.606	$13,459.482
Income (Loss) from Equity Method Investments	$-60.27	$9.045	$31.294	$51.123
Equity Securities, FV-NI, Gain (Loss)	—	—	$5,172.006	$5,172.006
Gain (Loss) on Termination of Lease	—	$94.551	$94.551	$94.551
Gain (Loss) on Extinguishment of Debt	$-163.278	$-40.491	$-2,135.854	$-1,616.205
Fair Value Adjustment of Warrants	—	—	$943.862	$6,394.247
InterestExpenseNonoperating	—	$1,056.36	$1,302.074	$1,130.46
Nonoperating Income (Expense)	$-1,239.671	$-993.255	$1,751.01	$548.923
Weighted Average Number of Shares Outstanding, Basic	1,565,951	309,539	117,083	1,690,988
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	4,842,438	926,595	1,099,986	608,556

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Temporary Equity, Carrying Amount, Attributable to Parent	—	—	$10,121.922	$10,121.922
Property, Plant and Equipment, Net	$826.418	$466.684	$386.165	$832.851
Operating Lease, Right-of-Use Asset	$5,740.929	$2,283.784	$1,286.217	$2,151.844
Intangible Assets, Net (Excluding Goodwill)	$4,093.431	$18,103.931	$1,325.145	$1,359.445
Goodwill	$5,878.986	$23,535.693	$5,878.986	$9,251.563
Other Long-term Investments	—	—	$2,466.81	$2,466.81
Assets Held-for-sale, Long Lived, Fair Value Disclosure	—	—	$32,484.707	$32,484.707
Assets	$20,887.787	$46,449.182	$20,220.124	$25,834.562
Operating Lease, Liability, Noncurrent	$5,522.09	$2,189.555	$1,171.075	$1,874.057
Notes Payable, Noncurrent	$1,253.997	$1,128.713	$744.725	$513.386
Deferred Income Tax Liabilities, Net	$1.949	—	$163.115	$56.129
Business Combination, Contingent Consideration, Liability, Noncurrent	$5,000	$5,000	$300	$300
Liabilities	$19,994.962	$26,244.709	$12,995.903	$9,342.984
Common Stock, Value, Issued	$0.249	$0.037	$0.239	$0.229
Additional Paid in Capital, Common Stock	$52,710.721	$49,537.054	$96,187.026	$112,126.967
Retained Earnings (Accumulated Deficit)	$-57,818.145	$-67,164.618	$-91,369.403	$-96,035.618
Stockholders' Equity Attributable to Parent	$892.825	$12,747.473	$7,224.221	$16,491.578
Cash	$232.424	$741.396	$2,077.842	$3,732.945
Accounts Receivable, after Allowance for Credit Loss, Current	$140.55	$174.881	$217.263	$257.729
Inventory, Net	$264.507	$219.764	$225.253	$251.29
Prepaid Expense and Other Assets, Current	$622.294	$182.29	$241.145	$360.801
Assets Held-for-sale, Not Part of Disposal Group, Current	—	—	$123.313	$123.313
Assets, Current	$1,259.775	$1,318.331	$2,761.503	$4,602.765
Accounts Payable and Accrued Liabilities, Current	$2,330.381	$5,713.956	$2,034.057	$1,601.018
Employee-related Liabilities, Current	$722.251	$2,122.93	$285.946	$450.141
Deferred Revenue, Current	$408.769	$602.359	$721.897	$788.498
Operating Lease, Liability, Current	$397.554	$239.125	$208.987	$407.568
Business Combination, Contingent Consideration, Liability, Current	$2,500	$2,500	$3,925	$2,098
Derivative Liability, Current	—	—	$1,881.078	$1,881.078
Other Liabilities, Current	$350	$410	$410	$47.812
Disposal Group, Including Discontinued Operation, Liabilities, Current	—	—	$4,294.521	$4,294.521
Liabilities, Current	$8,218.875	$17,926.441	$10,331.629	$6,519.724
Accounts Receivable, Allowance for Credit Loss	—	—	$69.641	$110.871
Preferred Stock, Shares Authorized	1,200,000	—	—	1,200,000
Common Stock, Shares Authorized	50,000,000	4,166,667	6,250,000	50,000,000
Common Stock, Shares, Issued	2,492,531	373,021	477,366	2,295,035
Equity Method Investments	$916.248	$740.759	$1,000	$613.771
Convertible Notes Payable, Current	—	—	$1,797.723	$2,888.947

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-8,034.612	$-9,095.838	$-23,323.054	$-5,285.221
Net Cash Provided by (Used in) Operating Activities	$-4,755.054	$-2,974.4	$-7,014.485	$-4,769.352
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$142.289	$508.972	$1,336.446	$3,183.764
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$232.424	$741.396	$2,077.842	$6,141.89
Issuance of Stock and Warrants for Services or Claims	$287.45	$1,246.765	$1,290.482	$716.858
Payments to Acquire Property, Plant, and Equipment	$444.722	$183.703	$43.412	$39.456
Employee Benefits and Share-based Compensation	$56.936	$0.153	$0.153	$0.153
Proceeds from Sale of Productive Assets	—	$75.59	$75.59	$75.59
Stock or Unit Option Plan Expense	$1,049.109	$342.728	$178.729	$284.821
Cash Acquired from Acquisition	—	$472.008	$472.008	—
Payments for (Proceeds from) Businesses and Interest in Affiliates	—	—	$6.569	$6.569
Amortization of Debt Discount (Premium)	$720.128	$622.283	$1,182.979	$1,182.979
Payments to Acquire Investments	—	—	$2,695.5	$2,695.5
Goodwill, Impairment Loss	—	—	$16,042.422	$16,042.422
Net Cash Provided by (Used in) Investing Activities	$-2,494.879	$363.895	$-2,745.481	$-2,927.601
Income (Loss) from Equity Method Investments	$-60.27	$9.045	$31.294	$51.123
Gain (Loss) on Extinguishment of Debt	$-163.278	$-40.491	$-2,135.854	$-1,616.205
Gain (Loss) on Disposition of Property Plant Equipment	—	$-511.663	$-511.663	$0
Gain (Loss) on Termination of Lease	—	$94.551	$94.551	$94.551
Gain (Loss) on Disposition of Assets	—	—	$-1,534.517	$-1,534.517
Fair Value Adjustment of Warrants	—	—	$943.862	$6,394.247
Equity Securities, FV-NI, Gain (Loss)	—	—	$5,172.006	$5,172.006
Gain (Loss) Related to Litigation Settlement	—	—	$929.5	$929.5
Depreciation, Depletion and Amortization	$200.894	$919.603	$677.364	$561.437
Increase (Decrease) in Equity Securities, FV-NI	—	$-4.534	$-4.534	$-4.534
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$924.678	$1,350.675	$-1,322.698	$-1,121.937
Increase (Decrease) in Employee Related Liabilities	$-224.011	$274.665	$-153.265	$-232.074
Increase (Decrease) in Deferred Revenue	$288.893	$193.59	$119.538	$-46.352
Increase (Decrease) in Other Current Liabilities	$-226.568	$-226.568	$-60	$-60
IncreaseDecreaseInOperatingLeaseLiability	$85.191	$25.869	$10.721	$37.25
Increase (Decrease) in Interest Payable, Net	$121.864	$166.772	$119.095	$31.646
Increase (Decrease) in Income Taxes Payable	—	—	$-163.115	$-163.115
Proceeds from (Repayments of) Notes Payable	—	—	$1,344.25	$1,344.25
Proceeds from Issuance of Common Stock	$5,701.948	$165.131	$12,355.607	$12,355.607
Proceeds from Issuance of Preferred Stock and Preference Stock	—	$1,643.904	$2,850	$2,850
Proceeds from Warrant Exercises	$23.051	$900.611	$1,110.604	$7,180.812
Payments for Repurchase of Trust Preferred Securities	—	—	$4,000	$4,000
Repayments of Notes Payable	$1,495.402	$934.419	$1,219.799	$232.8
Net Cash Provided by (Used in) Financing Activities	$7,392.222	$3,119.477	$11,096.412	$10,880.717
Interest Paid, Excluding Capitalized Interest, Operating Activities	$9.64	$214.742	$644.158	$776.306
Income Taxes Paid, Net	$0.8	—	—	$0.8
Liabilities Assumed	$490.668	$188.755	$167.863	$167.863
Increase (Decrease) in Accounts Receivable	$63.401	$34.331	$104.155	$103.125
Increase (Decrease) in Inventories	$0.905	$-44.743	$5.489	$16.064
Increase (Decrease) in Prepaid Expense and Other Assets	$432.093	$163.761	$120.472	$-51.477
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	—	$-870.594	$-24,418.153	$-24,418.153

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("IVF","financials")

Full statements spill as a table. For one cell: =jivedata("IVF","Revenue") or =jivedata("IVF","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.